mei'an pharmaceutical signed an agreement with rdbiomd uk
publisher:maxhealth date:2017-4-30
in april 2017, the company signed an agreement with peptest, a research and development and production company of gastroesophageal reflux diagnostic reagent, rdbiomd, uk, to acquire a 20.51% stake in the company by subscribing for its new and old shares.
[] []
